Broken String Biosciences

About Broken String Biosciences

Broken String Biosciences is a genomics company focused on enhancing the safety and efficacy of gene editing therapies to enable transformative therapeutics for patients. They aim to turn genomic breaks into breakthroughs using their innovative technologies.

Products & Services

INDUCE-seq® Technology:A game-changing technology for characterizing genome breaks in cell and gene therapy applications, enabling high-resolution detection of on- and off-target edits.

INDUCE-seq® On-Demand Solution:An exclusive early access program for gene therapy developers to detect edits in their own labs within days.

Catalyst Early Access Program (EAP):A program to shorten gene editing therapy development by months through high-resolution detection of edits.

SafeGuide (AI Tool):An AI tool developed in collaboration with BioLizard for selecting safer and better guide RNAs for gene editing.

Specialties

Gene Editing Safety Cell and Gene Therapy DNA Break-Mapping Technology AI for Gene Editing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 15000000 MR: - FA: 15 million FAN: 15000000	D: 2023-09-18 FD: 2023-09-18	5 investors

Series A Latest

2023-09-18

$15.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Laurence Reid

Chairman of the Board

LinkedIn (Pro only)

F

Felix Dobbs

Co-founder, CEO

LinkedIn (Pro only)

S

Simon Reed

Co-founder, CSO

LinkedIn (Pro only)

P

Patrick van Eijk

Co-founder, Staff Scientist

Y

Yoann Bonnamour

Investment Manager, Mérieux Equity Partners

B

Brad Crutchfield

Non-Executive Director

View 8 more team members with Pro

Unlock Full Team Directory

Recent News